help me understand receptor, I have read the wiki twice
Asking properly rather than in a comment on somebody else’s thread: help me understand receptor, I have read the wiki twice.
Why mechanism talk keeps misleading people, including me.
A mechanism tells you a direction. It does not tell you a magnitude, a timescale, or whether the pathway is operative at the exposures involved. "Receptor X is expressed in tissue Y" is a fact; "therefore effect Z in a person" is a hypothesis with several missing steps.
The corrective is boring and it works: ask whether the evidence is preclinical or human, ask what exposure was used, and read the limitations section before the abstract. Most of the confidently wrong posts on this board — several of them mine — skipped all three.
GLP-1 receptor agonism acts both peripherally — insulin secretion in a glucose-dependent way, slowed gastric emptying — and centrally, on appetite regulation. The central component is the better explanation for sustained intake reduction.
The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the difference is mediated by gut hormones. That is the foundation the whole class sits on.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
Long half-life in this class comes from structural modification that promotes albumin binding and resists enzymatic degradation. Weekly dosing is a consequence of the molecule, not a convenience decision.
the central appetite effect is doing more work than the gut effect
Read the primary paper after arguing about the summary for a fortnight. The discussion section said almost the opposite of what the thread had concluded.
Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.
Which receptor arm are you attributing that to?
Right — mechanism gives you a direction. It never gives you an effect size and people use it as though it does.
Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.
Right — mechanism gives you a direction.
Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.
Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.
Is that from a human study or a preclinical model?
The mental model, in four steps, that makes the rest of this site legible.
One: gut hormones amplify the insulin response to food. Two: agonists at those receptors act peripherally on insulin secretion and gastric emptying, and centrally on appetite. Three: structural modification gives them a long half-life, so exposure is smooth and weekly. Four: tolerance develops to some effects and not to others.
From those four, most of what the experience boards report falls out: why the side effects cluster early, why they settle at a stable dose, why appetite reduction persists, and why the scale and the appetite move on different clocks.
The mental model, in four steps, that makes the rest of this site legible.
Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.
The mental model, in four steps, that makes the rest of this site legible.
wholesome_lurker is right that mechanism gives direction and not magnitude. Worth pinning.
Yes. The central component is the one that explains the reports on this site better than gastric emptying does.
GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.
Agreed that receptor distribution is the key to the side-effect map. It is not a mystery, it is anatomy.
Small fix — it slows gastric emptying, it does not halt it, and the distinction matters for the mechanism you are proposing.
- 1Is that from a human study or a preclinical model?8 comments in this branch · started by u/milan_mensah
- 2Receptor expression in a tissue is necessary but not sufficient for an…7 comments in this branch · started by u/ferran_batista